RadNet Inc. (NASDAQ:RDNT) Director Marvin S. Cadwell sold 35,594 shares of the business’s stock in a transaction on Tuesday, March 13th. The stock was sold at an average price of $12.58, for a total value of $447,772.52. Following the completion of the transaction, the director now directly owns 266,384 shares of the company’s stock, valued at $3,351,110.72. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
RadNet Inc. (RDNT) traded up $0.30 during mid-day trading on Wednesday, reaching $12.95. The company’s stock had a trading volume of 697,861 shares, compared to its average volume of 202,552. RadNet Inc. has a 1 year low of $5.30 and a 1 year high of $13.40. The company has a debt-to-equity ratio of 7.88, a quick ratio of 1.29 and a current ratio of 1.29. The stock has a market capitalization of $616.73, a P/E ratio of 56.30, a PEG ratio of 2.67 and a beta of 0.69.
RadNet (NASDAQ:RDNT) last issued its earnings results on Thursday, March 8th. The medical research company reported $0.13 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.14 by ($0.01). RadNet had a return on equity of 26.66% and a net margin of 0.01%. The company had revenue of $235.50 million during the quarter, compared to analysts’ expectations of $228.46 million. During the same period in the previous year, the company earned $0.08 EPS. RadNet’s quarterly revenue was up 4.7% on a year-over-year basis. equities analysts predict that RadNet Inc. will post 0.58 earnings per share for the current fiscal year.
RDNT has been the subject of a number of analyst reports. BidaskClub raised RadNet from a “hold” rating to a “buy” rating in a report on Wednesday. Jefferies Group set a $14.00 target price on RadNet and gave the company a “buy” rating in a research note on Thursday, March 8th. Zacks Investment Research upgraded RadNet from a “hold” rating to a “buy” rating and set a $11.00 target price for the company in a research note on Thursday, January 4th. Raymond James Financial started coverage on RadNet in a research note on Wednesday. They issued a “strong-buy” rating and a $15.00 target price for the company. Finally, FIX started coverage on RadNet in a research note on Wednesday. They issued a “strong-buy” rating and a $15.00 target price for the company. One research analyst has rated the stock with a hold rating, two have given a buy rating and two have assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $13.75.
WARNING: This report was first reported by American Banking News and is owned by of American Banking News. If you are accessing this report on another website, it was stolen and republished in violation of United States & international trademark and copyright legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2018/03/14/marvin-s-cadwell-sells-35594-shares-of-radnet-inc-rdnt-stock.html.
RadNet Company Profile
RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.
Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.